Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Not Applicable

Active, not recruiting

Conditions: Pancreatic Cancer
Advanced Pancreatic Ductal Adenocarcinoma

Interventions: Drug: Gemcitabine
Drug: Nab-paclitaxel
Drug: PEGPH20

First Posted Date: 2016-09-30

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 110

Registration Number: NCT02921022

Locations: 🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 7 locations

Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes

Recruiting

Conditions: Ovarian Cancer
Prostate Cancer
Pancreas Cancer

Interventions: Behavioral: Assessments

First Posted Date: 2016-09-28

Last Posted Date: 2024-06-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1050

Registration Number: NCT02917798

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 2 locations

Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese Community

Early Phase 1

Active, not recruiting

Conditions: Lung Cancer Screening
Current or Past Cigarette Smoker

Interventions: Behavioral: Surveys
Behavioral: Focus groups
Behavioral: In-depth interviews
Behavioral: Navigation

First Posted Date: 2016-09-26

Last Posted Date: 2024-07-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 99

Registration Number: NCT02914899

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer

Completed

Conditions: Endometrial Cancer
Lymphedema

Interventions: Behavioral: questionnaire

First Posted Date: 2016-09-23

Last Posted Date: 2020-06-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 625

Registration Number: NCT02912767

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Phase 2

Completed

Conditions: Pediatric Patients With Solid Tumors

Interventions: Procedure: Sentinel Lymph Node Biopsy
Drug: indocyanine green (ICG)

First Posted Date: 2016-09-22

Last Posted Date: 2022-10-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT02910726

Locations: 🇺🇸
St. Jude's Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.

Completed

Conditions: Gastrointestinal Cancer

Interventions: Device: Electronic Activity Monitoring (EAM)
Behavioral: Daily Questionnaire

First Posted Date: 2016-09-21

Last Posted Date: 2020-08-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 54

Registration Number: NCT02909062

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States

and more 2 locations

Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma
Amyloidosis

Interventions: Device: Melphalan
Drug: Pegfilgrastim
Procedure: Autologous Hematopoietic Progenitor Cell Transplant

First Posted Date: 2016-09-21

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 46

Registration Number: NCT02909036

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study to Assess Thymic Function Using PET/CT and MRI

Completed

Conditions: CD34 Selected Peripheral Blood Stem Cell Graft

Interventions: Device: PET/CT scans
Device: MRI

First Posted Date: 2016-09-21

Last Posted Date: 2020-01-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT02909075

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

Phase 3

Active, not recruiting

Conditions: Radical Cystectomy

Interventions: Procedure: Surgery Radical Cystectomy
Procedure: Ultrapro mesh

First Posted Date: 2016-09-20

Last Posted Date: 2024-04-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 178

Registration Number: NCT02908061

Locations: 🇺🇸
Memorial Sloan Kettering Commack (Consent and follow-up only), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent and follow-up only), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Consent and follow-up only), Harrison, New York, United States

and more 4 locations

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Phase 1

Completed

Conditions: Abdominal Malignancy
Pelvic Malignancy

Interventions: Device: CivaSheet
Radiation: Brachytherapy
Procedure: surgical resection

First Posted Date: 2016-09-15

Last Posted Date: 2024-10-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02902107

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy